Vivolight Lights Up CIT 2026 with International Partners

CIT 2026 once again brought together clinicians, researchers, and industry leaders in interventional cardiology — this time with a clear message: progress in this field is inherently global. As one of the most influential interventional cardiology platforms in the Asia-Pacific region, CIT has long served as a bridge connecting Eastern and Western cardiology communities, fostering dialogue that transcends borders and disciplines.

At the opening ceremony, Prof. Gary Mintz (CRF) congratulated the return of CIT and emphasized that interventional cardiology relies on international collaboration and mutual learning — a principle that has never been more relevant as the field moves toward increasingly sophisticated imaging-guided and physiology-guided interventions. Prof. William Wijns (EuroPCR) echoed this sentiment, celebrating the long-standing partnership between EuroPCR and CIT and looking ahead to broader academic exchange and deeper cross-regional cooperation.

During the congress, Vivolight Medical hosted an international delegation for a focused exchange centered on optical coherence tomography (OCT) in coronary intervention. The delegation, comprising clinicians with active practices in interventional cardiology, brought diverse clinical perspectives and a shared interest in understanding how OCT-based technologies can be integrated into daily practice. For Vivolight, this was more than congress participation — it was about creating practical clinical dialogue around OCT-based decision-making, workflow optimization, and real-world PCI applications. The exchange allowed both sides to discuss unmet clinical needs, share procedural experiences, and explore how emerging technologies can address everyday challenges in the cath lab.

On April 17, the customer delegation attended the “One-stop Intravascular Imaging & Functional Evaluation for Precise Diagnosis and Treatment Training Symposium” held during CIT 2026.

The symposium focused on the integration of intravascular imaging and functional evaluation in coronary artery disease. Topics covered during the session included image- and function-guided treatment strategy, OCT-FFR application, OCT-guided drug-coated balloon treatment, and OCT-guided complex cases.

Through the symposium, the international delegation gained a broader understanding of how OCT and its functional evaluation can support more precise diagnosis, treatment planning, and procedural assessment in coronary intervention. The academic program also provided a valuable setting for them to observe how clinical experts discuss imaging-based strategies in complex coronary scenarios. In particular, OCT-derived FFR (OCT-FFR) was discussed as a multimodal functions that enables functional assessment, helping streamline workflow by reducing the need for additional procedures, cost, and procedure time.

Beyond the academic sessions, the delegation also explored the exhibition area, engaging with the latest technologies and solutions in cardiovascular intervention. From next-generation imaging systems to novel interventional devices, the exhibition floor offered a comprehensive view of where the field is heading. The delegation exchanged views with industry representatives on current innovation trends, gaining first-hand insight into the competitive landscape and the direction of technology development in interventional cardiology.

By participating in CIT 2026, Vivolight Medical continued to engage with clinicians and partners worldwide, supporting education, dialogue, and the clinical application of multimodal OCT technologies in coronary intervention.